| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962059 | Tuberculosis | 2014 | 15 Pages |
Abstract
M72/AS01 given to infants after or concomitantly with EPI vaccines had an acceptable safety profile. Our results suggest no interference of immunogenicity profiles occurred following co-administration of M72/AS01 and EPI vaccines. Two M72/AS01 doses elicited higher immune responses than one dose.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Olubukola T. Idoko, Olumuyiwa A. Owolabi, Patrick K. Owiafe, Philippe Moris, Aderonke Odutola, Anne Bollaerts, Ezra Ogundare, Erik Jongert, Marie-Ange Demoitié, Opokua Ofori-Anyinam, Martin O. Ota,